24 June 2021Aravive (ARAV.Q) Announces Positive Initial Results from Phase 1b Portion…Kieran Robertson Aravive (ARAV.Q), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, announced positive initial results today from the Phase 1b portion of its Phase 1b/2 study of…